Long-term theranostic hydrogel system for solid tumors
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Lanthanide and Transition Metal Complexes · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Resonance absorption by nuclear magnetic moments in a solid10.1103/PhysRev.69.37 ↗
2. Image formation by induced local interactions: examples employing nuclear magnetic resonance10.1038/242190a0 ↗
3. Magnetic resonance zeugmatography10.1351/pac197440010149 ↗
4. FONAR image of the live human body
5. MR Neurography and diffusion tensor imaging: origins, history & clinical impact
6. Magnetic nanoparticle probes
7. Superparamagnetic iron oxide: Pharmacokinetics and toxicity10.2214/ajr.152.1.167 ↗
8. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging10.1148/radiology.175.2.2326475 ↗
9. High sensitivity lanthanide(III) based probes for MR-medical imaging10.1016/j.ccr.2006.03.015 ↗
10. Recent advances in iron oxide nanocrystal technology for medical imaging10.1016/j.addr.2006.09.013 ↗
11. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging10.1038/nm1467 ↗
12. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects10.1097/00002142-199806000-00003 ↗
13. Phase I clinical evaluation of a new iron oxide MR contrast agent10.1002/jmri.1880040313 ↗
14. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent10.1002/jmri.20235 ↗
15. Reimer · J Magn Reson Imaging · 1997 · 7 · 94510.1002/jmri.1880070602 ↗
16. Ultrasmall supraparamagnetic iron oxide-enhanced Magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol10.1097/01.rli.0000191367.61306.83 ↗
17. Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions10.1016/S1076-6332(03)00248-4 ↗
18. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging10.1097/01.rli.0000129472.45832.b0 ↗
19. Nanoparticle-based theranostic agents10.1016/j.addr.2010.07.009 ↗
20. Multifunctional magnetic nanoparticles for targeted imaging and therapy10.1016/j.addr.2008.03.014 ↗
21. Imaging and drug delivery using theranostic nanoparticles10.1016/j.addr.2010.08.004 ↗
22. Engineered polymers for advanced drug delivery10.1016/j.ejpb.2008.09.021 ↗
23. Drug delivery and transport to solid tumors10.1023/A:1025785505977 ↗
24. Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system10.1023/A:1016054807555 ↗
25. Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors10.1016/S0169-409X(99)00038-1 ↗
26. Synthesis and characterization of biodegradable thermosensitive poly(organophosphazene) gels10.1021/ma0305838 ↗
27. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels10.1016/j.ijpharm.2006.03.032 ↗
28. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications10.1016/j.biomaterials.2008.12.083 ↗
29. The use of injectable, thermosensitive poly(organophosphazene)-RGD conjugates for the enhancement of mesenchymal stem cell osteogenic differentiation10.1016/j.biomaterials.2009.08.011 ↗
30. Chun · Biomaterials · 2009 · 30 · 475210.1016/j.biomaterials.2009.05.031 ↗
31. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice10.1016/j.jconrel.2009.10.003 ↗
32. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
33. An overview of the structure and magnetism of spinel ferrite nanoparticles and their synthesis in microemulsions10.1016/j.cej.2006.11.001 ↗
34. Size-controlled synthesis of magnetite nanoparticles10.1021/ja026501x ↗
35. Monodisperse MFe2O4 (M=Fe, Co, Mn) nanoparticles10.1021/ja0380852 ↗
36. Shape control and associated magnetic properties of spinel cobalt ferrite nanocrystals10.1021/ja049931r ↗
37. On the development of colloidal nanoparticles towards multifunctional structures and their possible use for biological applications10.1002/smll.200400071 ↗
38. Self-assembly in aqueous solutions of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)-b-poly(vinyl alcohol)10.1021/la990946q ↗
39. Surface passivation of luminescent colloidal quantum dots with poly(dimethylaminoethyl methacrylate) through a ligand exchange process10.1021/ja0489339 ↗
40. Quantum dot bioconjugates for imaging, labelling and sensing10.1038/nmat1390 ↗
41. Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications10.1021/cm0507819 ↗
42. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-baed nanoparticles for conjugation with cell targeting agents10.1021/ja049195r ↗
43. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake10.1016/S0142-9612(01)00267-8 ↗
44. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications10.1351/pac200678051003 ↗
45. Magnetic properties of stable dispersions of subdomain magnetite particles10.1063/1.1658812 ↗
46. Influence of iron oleate complex structure on iron oxide nanoparticle formation10.1021/cm062948j ↗
47. Thermosensitive/magnetic poly(organophosphazene) hydrogel as a long-term magnetic resonance contrast platform10.1016/j.biomaterials.2011.09.033 ↗
48. A new class of biodegradable thermosensitive polymers. 2. Hydrolytic properties and salt effect on the lower critical solution temperature of poly(organophosphazenes) with methoxypoly(ethylene glycol) and amino acid esters as side groups10.1021/ma990645n ↗
49. Thermosensitive poly(organophosphazene) hydrogels for a controlled drug delivery10.1016/j.ejpb.2006.01.001 ↗